OS Therapies & Can-Fite BioPharma 将于 8 月 10 日在彭博电视台的 RedChip 节目中讨论最近的进展。 OS Therapies & Can-Fite BioPharma will discuss recent progress on Bloomberg TV's RedChip show on Aug 10.

OS Therapies & Can-Fite BioPharma 将于 8 月 10 日在彭博电视的 RedChip Small Stocks， Big Money 节目中亮相，讨论最近的发展、战略计划和潜在收入。 OS Therapies & Can-Fite BioPharma to be featured on RedChip Small Stocks, Big Money show on Bloomberg TV on August 10, discussing recent developments, strategic plans, and potential revenues. OS治疗的重点是骨质瘤和固态肿瘤治疗,而Can-Fite生物药剂则侧重于肿瘤学和炎症的口服药物。 OS Therapies is focused on Osteosarcoma and solid tumor treatments, while Can-Fite BioPharma focuses on oral drugs for oncology and inflammatory diseases. 两家公司的药物候选人都取得了有利结果。 Both companies have experienced favorable results with their drug candidates.